Aurisco Pharmaceutical Subsidiary's Worksops Pass US FDA Inspection; Shares Rise 3%

MT Newswires Live
08/13

Aurisco Pharmaceutical (SHA:605116) subsidiary Yangzhou Aurisco Pharmaceutical's quality management system passed an inspection by the U.S. Food and Drug Administration, according to a Thursday filing with the Shanghai bourse.

The FDA inspected Yangzhou Aurisco's workshops in Jiangsu, China from June 15 to 19, covering its production facilities and found the workshops to be in compliance with current good manufacturing practice standards, the filing said.

Shares rose 3% during afternoon trading on Thursday.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10